CCFM
LEGN icon

Clear Creek Financial Management’s Legend Biotech LEGN Stock Holding History

Clear Creek Financial Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,750
Closed -$303K – 662
2026
Q1 		$303K Buy
16,750
+6,750
+68% +$129K 0.02% 498
2025
Q4 		$217K Buy
+10,000
New +$286K 0.02% 543

Other funds holding LEGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
IAMH
IvyRock Asset Management (HK) Sheung Wan, Hong Kong $177M AUM 10.49% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return
ELI
Empire Life Investments Toronto, Ontario, Canada $1.79B AUM 38.49% 1-Year Est. Return

Clear Creek Financial Management's LEGN Position: Q2 2026 in Review

Clear Creek Financial Management sold out of Legend Biotech (LEGN) in Q2 2026, closing a stake of 16,750 shares — an estimated $303K sold.

Clear Creek Financial Management first reported a position in LEGN in Q4 2025 and held it in 2 quarters. The position peaked at $303K in Q1 2026. 92 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Clear Creek Financial Management reported no remaining Legend Biotech position as of Q2 2026 after selling out during the quarter.
  • Clear Creek Financial Management sold 16,750 Legend Biotech shares in Q2 2026, an estimated $303K.
  • Clear Creek Financial Management first reported a position in Legend Biotech in Q4 2025 and held it in 2 quarters.
  • Clear Creek Financial Management's Legend Biotech position peaked at $303K in Q1 2026.
  • 92 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Clear Creek Financial Management's 13F filing for Q2 2026, filed 28 Jul 2026.